Dimensional Fund Advisors LP 13D and 13G filings for Anika Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-23 3:55 pm Sale | 2024-12-31 | 13G | Anika Therapeutics, Inc. ANIK | Dimensional Fund Advisors LP | 657,355 4.500% | -164,097 (-19.98%) | Filing |
| 2024-02-09 09:59 am Sale | 2024-02-14 | 13G | Anika Therapeutics, Inc. ANIK | Dimensional Fund Advisors LP | 821,452 5.600% | -138,294 (-14.41%) | Filing |
| 2023-02-10 2:42 pm Purchase | 2023-02-14 | 13G | Anika Therapeutics, Inc. ANIK | Dimensional Fund Advisors LP | 959,746 6.600% | 103,622 (+12.10%) | Filing |
| 2022-02-08 3:52 pm Sale | 2022-02-14 | 13G | Anika Therapeutics, Inc. ANIK | Dimensional Fund Advisors LP | 856,124 5.900% | -27,992 (-3.17%) | Filing |
| 2021-02-12 3:55 pm Sale | 2021-02-16 | 13G | Anika Therapeutics, Inc. ANIK | Dimensional Fund Advisors LP | 884,116 6.200% | -117,178 (-11.70%) | Filing |